Safety and efficacy of Sofosbuvir/Velpatasvir in pediatric patients 6 to < 18 years old with chronic hepatitis C infection

Jonas, Maureen; Romero, René; Sokal, Etienne

Safety and efficacy of Sofosbuvir/Velpatasvir in pediatric patients 6 to < 18 years old with chronic hepatitis C infection

Jonas, Maureen

;

Romero, René

;

Sokal, Etienne

;et.al.

(2019) The Liver Meeting AASLD (American Association of the Study of Liver Diseases) — Location: Boston, USA (8.November.2019)

Files

ABSTRACT748.pdf

Open Access
Adobe PDF
328.45 KB

Download

Details

Authors

Jonas, MaureenBoston Children's Hospital
Author
Romero, RenéChildren's Healthcare of Atlanta
Author
Sokal, EtienneUCLouvain
Author
et. al.

Affiliations

UCLouvainSSS/IREC/PEDI - Pôle de Pédiatrie
UCLouvain(SLuc) Service de gastro-entérologie et hépatologie pédiatrique

Citations

APA
Chicago
FWB

Jonas, M., Romero, R., Sokal, E., & et al. (2019). Safety and efficacy of Sofosbuvir/Velpatasvir in pediatric patients 6 to < 18 years old with chronic hepatitis C infection. Hepatology, November, abstract 748. https://hdl.handle.net/2078.5/124763 (Original work published 2019)